Cortesi E - Search Results

1

Delivery optimization of erlotinib according to toxicity: may clinical practice go beyond research?

Passaro A, Fasano M, Bria E, Morgillo F, Cantile F, Alesini D, Pellegrino A, Cortesi E, Ciardiello F. Passaro A, et al. Among authors: cortesi e. Lung Cancer. 2013 Jun;80(3):352-3. doi: 10.1016/j.lungcan.2013.01.023. Epub 2013 Feb 26. Lung Cancer. 2013. PMID: 23453130 No abstract available.

2

Erlotinib and gefitinib for elderly patients with advanced non-small-cell lung cancer.

Passaro A, Alesini D, Pochesci A, Cortesi E. Passaro A, et al. Among authors: cortesi e. Anticancer Agents Med Chem. 2014 Jun;14(5):646-50. doi: 10.2174/187152061405140501101624. Anticancer Agents Med Chem. 2014. PMID: 23140355 Review.

3

Second-line treatment of non-small-cell lung cancer: chemotherapy or tyrosine kinase inhibitors?

Passaro A, Cortesi E, de Marinis F. Passaro A, et al. Among authors: cortesi e. Expert Rev Anticancer Ther. 2011 Oct;11(10):1587-97. doi: 10.1586/era.11.120. Expert Rev Anticancer Ther. 2011. PMID: 21999132 Review.

4

Neoadjuvant EGFR TKIs: toward personalized management in non-small-cell lung cancer.

Passaro A, Cortesi E. Passaro A, et al. Among authors: cortesi e. Transl Lung Cancer Res. 2012 Dec;1(4):280-2. doi: 10.3978/j.issn.2218-6751.2012.09.11. Transl Lung Cancer Res. 2012. PMID: 25806194 Free PMC article. No abstract available.

5

The impact of chemotherapy on the lymphatic system in thoracic oncology.

Passaro A, Trenta P, Conte D, Campennì G, De Benedetto A, Cortesi E. Passaro A, et al. Among authors: cortesi e. Thorac Surg Clin. 2012 May;22(2):243-9. doi: 10.1016/j.thorsurg.2011.11.002. Epub 2011 Dec 29. Thorac Surg Clin. 2012. PMID: 22520292 Review.

6

Multimodality treatment of gynecomastia in patients receiving antiandrogen therapy for prostate cancer in the era of abiraterone acetate and new antiandrogen molecules.

Alesini D, Iacovelli R, Palazzo A, Altavilla A, Risi E, Urbano F, Manai C, Passaro A, Magri V, Cortesi E. Alesini D, et al. Among authors: cortesi e. Oncology. 2013;84(2):92-9. doi: 10.1159/000343821. Epub 2012 Nov 2. Oncology. 2013. PMID: 23128186 Review.

7

Molecular and clinical analysis of predictive biomarkers in non-small-cell lung cancer.

Passaro A, Palazzo A, Trenta P, Mancini ML, Morano F, Cortesi E. Passaro A, et al. Among authors: cortesi e. Curr Med Chem. 2012;19(22):3689-700. doi: 10.2174/092986712801661149. Curr Med Chem. 2012. PMID: 22680928 Review.

8

Medical strategies for treatment of castration resistant prostate cancer (CRPC) docetaxel resistant.

Altavilla A, Iacovelli R, Procopio G, Alesini D, Risi E, Campennì GM, Palazzo A, Cortesi E. Altavilla A, et al. Among authors: cortesi e. Cancer Biol Ther. 2012 Sep;13(11):1001-8. doi: 10.4161/cbt.21188. Epub 2012 Jul 24. Cancer Biol Ther. 2012. PMID: 22825325 Free PMC article. Review.

9

Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. A meta-analysis of published trials.

Iacovelli R, Alesini D, Palazzo A, Trenta P, Santoni M, De Marchis L, Cascinu S, Naso G, Cortesi E. Iacovelli R, et al. Among authors: cortesi e. Cancer Treat Rev. 2014 Mar;40(2):271-5. doi: 10.1016/j.ctrv.2013.09.003. Epub 2013 Sep 11. Cancer Treat Rev. 2014. PMID: 24070900 Review.

10

Clinical experience with everolimus in the second-line treatment of advanced renal cell carcinoma.

Alesini D, Mosillo C, Naso G, Cortesi E, Iacovelli R. Alesini D, et al. Among authors: cortesi e. Ther Adv Urol. 2015 Oct;7(5):286-94. doi: 10.1177/1756287215591764. Ther Adv Urol. 2015. PMID: 26425143 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters